Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00328978Phase 3Completed
A Phase 3 trial of quetiapine in schizophrenia, schizoaffective disorder, sponsored by AstraZeneca. Started Oct 2003; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00328978.